 | • レポートコード：QYR2104Z0107 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、養子細胞療法（ACT）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CAR-T、TCR-T、NK、TIL）、用途別市場規模（リンパ腫、白血病）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・養子細胞療法（ACT）の市場動向 ・企業の競争状況、市場シェア ・養子細胞療法（ACT）の種類別市場規模（CAR-T、TCR-T、NK、TIL） ・養子細胞療法（ACT）の用途別市場規模（リンパ腫、白血病） ・養子細胞療法（ACT）の北米市場規模2016-2027（アメリカ、カナダ） ・養子細胞療法（ACT）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・養子細胞療法（ACT）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・養子細胞療法（ACT）の中南米市場規模2016-2027（メキシコ、ブラジル） ・養子細胞療法（ACT）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis、Juno、Kite、Adaptimmune、Fibrocell、Lineage Cell Therapeutics、BioTime、Vericel Corporation、Regeneus、Anhui Anke Biotechnology、Cellectis、NantKwest、SorrentoTherapeutics、Bellicum） ・結論 |
Adoptive cell therapy, also known as cellular immunotherapy, is a form of treatment that uses the cells of our immune system to eliminate cancer.
Market Analysis and Insights: Global Adoptive Cell Therapy Market
The global Adoptive Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Adoptive Cell Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Adoptive Cell Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Adoptive Cell Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Adoptive Cell Therapy market.
Global Adoptive Cell Therapy Scope and Market Size
Adoptive Cell Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Adoptive Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
CAR-T
TCR-T
NK
TIL
Segment by Application
Lymphoma
Leukemia
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Novartis
Juno
Kite
Adaptimmune
Fibrocell
Lineage Cell Therapeutics
BioTime
Vericel Corporation
Regeneus
Adaptimmune
Fibrocell
NantKwest
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adoptive Cell Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 CAR-T
1.2.3 TCR-T
1.2.4 NK
1.2.5 TIL
1.3 Market by Application
1.3.1 Global Adoptive Cell Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Lymphoma
1.3.3 Leukemia
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Adoptive Cell Therapy Market Perspective (2016-2027)
2.2 Adoptive Cell Therapy Growth Trends by Regions
2.2.1 Adoptive Cell Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Adoptive Cell Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Adoptive Cell Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Adoptive Cell Therapy Industry Dynamic
2.3.1 Adoptive Cell Therapy Market Trends
2.3.2 Adoptive Cell Therapy Market Drivers
2.3.3 Adoptive Cell Therapy Market Challenges
2.3.4 Adoptive Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adoptive Cell Therapy Players by Revenue
3.1.1 Global Top Adoptive Cell Therapy Players by Revenue (2016-2021)
3.1.2 Global Adoptive Cell Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Adoptive Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Adoptive Cell Therapy Revenue
3.4 Global Adoptive Cell Therapy Market Concentration Ratio
3.4.1 Global Adoptive Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adoptive Cell Therapy Revenue in 2020
3.5 Adoptive Cell Therapy Key Players Head office and Area Served
3.6 Key Players Adoptive Cell Therapy Product Solution and Service
3.7 Date of Enter into Adoptive Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adoptive Cell Therapy Breakdown Data by Type
4.1 Global Adoptive Cell Therapy Historic Market Size by Type (2016-2021)
4.2 Global Adoptive Cell Therapy Forecasted Market Size by Type (2022-2027)
5 Adoptive Cell Therapy Breakdown Data by Application
5.1 Global Adoptive Cell Therapy Historic Market Size by Application (2016-2021)
5.2 Global Adoptive Cell Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Adoptive Cell Therapy Market Size (2016-2027)
6.2 North America Adoptive Cell Therapy Market Size by Type
6.2.1 North America Adoptive Cell Therapy Market Size by Type (2016-2021)
6.2.2 North America Adoptive Cell Therapy Market Size by Type (2022-2027)
6.2.3 North America Adoptive Cell Therapy Market Size by Type (2016-2027)
6.3 North America Adoptive Cell Therapy Market Size by Application
6.3.1 North America Adoptive Cell Therapy Market Size by Application (2016-2021)
6.3.2 North America Adoptive Cell Therapy Market Size by Application (2022-2027)
6.3.3 North America Adoptive Cell Therapy Market Size by Application (2016-2027)
6.4 North America Adoptive Cell Therapy Market Size by Country
6.4.1 North America Adoptive Cell Therapy Market Size by Country (2016-2021)
6.4.2 North America Adoptive Cell Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Adoptive Cell Therapy Market Size (2016-2027)
7.2 Europe Adoptive Cell Therapy Market Size by Type
7.2.1 Europe Adoptive Cell Therapy Market Size by Type (2016-2021)
7.2.2 Europe Adoptive Cell Therapy Market Size by Type (2022-2027)
7.2.3 Europe Adoptive Cell Therapy Market Size by Type (2016-2027)
7.3 Europe Adoptive Cell Therapy Market Size by Application
7.3.1 Europe Adoptive Cell Therapy Market Size by Application (2016-2021)
7.3.2 Europe Adoptive Cell Therapy Market Size by Application (2022-2027)
7.3.3 Europe Adoptive Cell Therapy Market Size by Application (2016-2027)
7.4 Europe Adoptive Cell Therapy Market Size by Country
7.4.1 Europe Adoptive Cell Therapy Market Size by Country (2016-2021)
7.4.2 Europe Adoptive Cell Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Adoptive Cell Therapy Market Size (2016-2027)
8.2 Asia-Pacific Adoptive Cell Therapy Market Size by Type
8.2.1 Asia-Pacific Adoptive Cell Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Adoptive Cell Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Adoptive Cell Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Adoptive Cell Therapy Market Size by Application
8.3.1 Asia-Pacific Adoptive Cell Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Adoptive Cell Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Adoptive Cell Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Adoptive Cell Therapy Market Size by Region
8.4.1 Asia-Pacific Adoptive Cell Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Adoptive Cell Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Adoptive Cell Therapy Market Size (2016-2027)
9.2 Latin America Adoptive Cell Therapy Market Size by Type
9.2.1 Latin America Adoptive Cell Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Adoptive Cell Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Adoptive Cell Therapy Market Size by Type (2016-2027)
9.3 Latin America Adoptive Cell Therapy Market Size by Application
9.3.1 Latin America Adoptive Cell Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Adoptive Cell Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Adoptive Cell Therapy Market Size by Application (2016-2027)
9.4 Latin America Adoptive Cell Therapy Market Size by Country
9.4.1 Latin America Adoptive Cell Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Adoptive Cell Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adoptive Cell Therapy Market Size (2016-2027)
10.2 Middle East & Africa Adoptive Cell Therapy Market Size by Type
10.2.1 Middle East & Africa Adoptive Cell Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Adoptive Cell Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Adoptive Cell Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Adoptive Cell Therapy Market Size by Application
10.3.1 Middle East & Africa Adoptive Cell Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Adoptive Cell Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Adoptive Cell Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Adoptive Cell Therapy Market Size by Country
10.4.1 Middle East & Africa Adoptive Cell Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Adoptive Cell Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Adoptive Cell Therapy Introduction
11.1.4 Novartis Revenue in Adoptive Cell Therapy Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Juno
11.2.1 Juno Company Details
11.2.2 Juno Business Overview
11.2.3 Juno Adoptive Cell Therapy Introduction
11.2.4 Juno Revenue in Adoptive Cell Therapy Business (2016-2021)
11.2.5 Juno Recent Development
11.3 Kite
11.3.1 Kite Company Details
11.3.2 Kite Business Overview
11.3.3 Kite Adoptive Cell Therapy Introduction
11.3.4 Kite Revenue in Adoptive Cell Therapy Business (2016-2021)
11.3.5 Kite Recent Development
11.4 Adaptimmune
11.4.1 Adaptimmune Company Details
11.4.2 Adaptimmune Business Overview
11.4.3 Adaptimmune Adoptive Cell Therapy Introduction
11.4.4 Adaptimmune Revenue in Adoptive Cell Therapy Business (2016-2021)
11.4.5 Adaptimmune Recent Development
11.5 Fibrocell
11.5.1 Fibrocell Company Details
11.5.2 Fibrocell Business Overview
11.5.3 Fibrocell Adoptive Cell Therapy Introduction
11.5.4 Fibrocell Revenue in Adoptive Cell Therapy Business (2016-2021)
11.5.5 Fibrocell Recent Development
11.6 Lineage Cell Therapeutics
11.6.1 Lineage Cell Therapeutics Company Details
11.6.2 Lineage Cell Therapeutics Business Overview
11.6.3 Lineage Cell Therapeutics Adoptive Cell Therapy Introduction
11.6.4 Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2016-2021)
11.6.5 Lineage Cell Therapeutics Recent Development
11.7 BioTime
11.7.1 BioTime Company Details
11.7.2 BioTime Business Overview
11.7.3 BioTime Adoptive Cell Therapy Introduction
11.7.4 BioTime Revenue in Adoptive Cell Therapy Business (2016-2021)
11.7.5 BioTime Recent Development
11.8 Vericel Corporation
11.8.1 Vericel Corporation Company Details
11.8.2 Vericel Corporation Business Overview
11.8.3 Vericel Corporation Adoptive Cell Therapy Introduction
11.8.4 Vericel Corporation Revenue in Adoptive Cell Therapy Business (2016-2021)
11.8.5 Vericel Corporation Recent Development
11.9 Regeneus
11.9.1 Regeneus Company Details
11.9.2 Regeneus Business Overview
11.9.3 Regeneus Adoptive Cell Therapy Introduction
11.9.4 Regeneus Revenue in Adoptive Cell Therapy Business (2016-2021)
11.9.5 Regeneus Recent Development
11.10 Anhui Anke Biotechnology
11.10.1 Anhui Anke Biotechnology Company Details
11.10.2 Anhui Anke Biotechnology Business Overview
11.10.3 Anhui Anke Biotechnology Adoptive Cell Therapy Introduction
11.10.4 Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2016-2021)
11.10.5 Anhui Anke Biotechnology Recent Development
11.11 Cellectis
11.11.1 Cellectis Company Details
11.11.2 Cellectis Business Overview
11.11.3 Cellectis Adoptive Cell Therapy Introduction
11.11.4 Cellectis Revenue in Adoptive Cell Therapy Business (2016-2021)
11.11.5 Cellectis Recent Development
11.12 NantKwest
11.12.1 NantKwest Company Details
11.12.2 NantKwest Business Overview
11.12.3 NantKwest Adoptive Cell Therapy Introduction
11.12.4 NantKwest Revenue in Adoptive Cell Therapy Business (2016-2021)
11.12.5 NantKwest Recent Development
11.13 SorrentoTherapeutics
11.13.1 SorrentoTherapeutics Company Details
11.13.2 SorrentoTherapeutics Business Overview
11.13.3 SorrentoTherapeutics Adoptive Cell Therapy Introduction
11.13.4 SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2016-2021)
11.13.5 SorrentoTherapeutics Recent Development
11.14 Bellicum
11.14.1 Bellicum Company Details
11.14.2 Bellicum Business Overview
11.14.3 Bellicum Adoptive Cell Therapy Introduction
11.14.4 Bellicum Revenue in Adoptive Cell Therapy Business (2016-2021)
11.14.5 Bellicum Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Adoptive Cell Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of CAR-T
Table 3. Key Players of TCR-T
Table 4. Key Players of NK
Table 5. Key Players of TIL
Table 6. Global Adoptive Cell Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Adoptive Cell Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Adoptive Cell Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Adoptive Cell Therapy Market Share by Regions (2016-2021)
Table 10. Global Adoptive Cell Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Adoptive Cell Therapy Market Share by Regions (2022-2027)
Table 12. Adoptive Cell Therapy Market Trends
Table 13. Adoptive Cell Therapy Market Drivers
Table 14. Adoptive Cell Therapy Market Challenges
Table 15. Adoptive Cell Therapy Market Restraints
Table 16. Global Adoptive Cell Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Adoptive Cell Therapy Market Share by Players (2016-2021)
Table 18. Global Top Adoptive Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adoptive Cell Therapy as of 2020)
Table 19. Ranking of Global Top Adoptive Cell Therapy Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Adoptive Cell Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Adoptive Cell Therapy Product Solution and Service
Table 23. Date of Enter into Adoptive Cell Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Adoptive Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Adoptive Cell Therapy Revenue Market Share by Type (2016-2021)
Table 27. Global Adoptive Cell Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Adoptive Cell Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Adoptive Cell Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Adoptive Cell Therapy Revenue Market Share by Application (2016-2021)
Table 31. Global Adoptive Cell Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Adoptive Cell Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Adoptive Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Adoptive Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Adoptive Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Adoptive Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Adoptive Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Adoptive Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Adoptive Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Adoptive Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Adoptive Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Adoptive Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Adoptive Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Adoptive Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Adoptive Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Adoptive Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Adoptive Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Adoptive Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Adoptive Cell Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Adoptive Cell Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Adoptive Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Adoptive Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Adoptive Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Adoptive Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Adoptive Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Adoptive Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Adoptive Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Adoptive Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Adoptive Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Adoptive Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Adoptive Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Adoptive Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 63. Novartis Company Details
Table 64. Novartis Business Overview
Table 65. Novartis Adoptive Cell Therapy Product
Table 66. Novartis Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
Table 67. Novartis Recent Development
Table 68. Juno Company Details
Table 69. Juno Business Overview
Table 70. Juno Adoptive Cell Therapy Product
Table 71. Juno Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
Table 72. Juno Recent Development
Table 73. Kite Company Details
Table 74. Kite Business Overview
Table 75. Kite Adoptive Cell Therapy Product
Table 76. Kite Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
Table 77. Kite Recent Development
Table 78. Adaptimmune Company Details
Table 79. Adaptimmune Business Overview
Table 80. Adaptimmune Adoptive Cell Therapy Product
Table 81. Adaptimmune Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
Table 82. Adaptimmune Recent Development
Table 83. Fibrocell Company Details
Table 84. Fibrocell Business Overview
Table 85. Fibrocell Adoptive Cell Therapy Product
Table 86. Fibrocell Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
Table 87. Fibrocell Recent Development
Table 88. Lineage Cell Therapeutics Company Details
Table 89. Lineage Cell Therapeutics Business Overview
Table 90. Lineage Cell Therapeutics Adoptive Cell Therapy Product
Table 91. Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
Table 92. Lineage Cell Therapeutics Recent Development
Table 93. BioTime Company Details
Table 94. BioTime Business Overview
Table 95. BioTime Adoptive Cell Therapy Product
Table 96. BioTime Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
Table 97. BioTime Recent Development
Table 98. Vericel Corporation Company Details
Table 99. Vericel Corporation Business Overview
Table 100. Vericel Corporation Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
Table 101. Vericel Corporation Recent Development
Table 102. Regeneus Company Details
Table 103. Regeneus Business Overview
Table 104. Regeneus Adoptive Cell Therapy Product
Table 105. Regeneus Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
Table 106. Regeneus Recent Development
Table 107. Anhui Anke Biotechnology Company Details
Table 108. Anhui Anke Biotechnology Business Overview
Table 109. Anhui Anke Biotechnology Adoptive Cell Therapy Product
Table 110. Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
Table 111. Anhui Anke Biotechnology Recent Development
Table 112. Cellectis Company Details
Table 113. Cellectis Business Overview
Table 114. Cellectis Adoptive Cell Therapy Product
Table 115. Cellectis Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
Table 116. Cellectis Recent Development
Table 117. NantKwest Company Details
Table 118. NantKwest Business Overview
Table 119. NantKwest Adoptive Cell Therapy Product
Table 120. NantKwest Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
Table 121. NantKwest Recent Development
Table 122. SorrentoTherapeutics Company Details
Table 123. SorrentoTherapeutics Business Overview
Table 124. SorrentoTherapeutics Adoptive Cell Therapy Product
Table 125. SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
Table 126. SorrentoTherapeutics Recent Development
Table 127. Bellicum Company Details
Table 128. Bellicum Business Overview
Table 129. Bellicum Adoptive Cell Therapy Product
Table 130. Bellicum Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
Table 131. Bellicum Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adoptive Cell Therapy Market Share by Type: 2020 VS 2027
Figure 2. CAR-T Features
Figure 3. TCR-T Features
Figure 4. NK Features
Figure 5. TIL Features
Figure 6. Global Adoptive Cell Therapy Market Share by Application: 2020 VS 2027
Figure 7. Lymphoma Case Studies
Figure 8. Leukemia Case Studies
Figure 9. Adoptive Cell Therapy Report Years Considered
Figure 10. Global Adoptive Cell Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Adoptive Cell Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Adoptive Cell Therapy Market Share by Regions: 2020 VS 2027
Figure 13. Global Adoptive Cell Therapy Market Share by Regions (2022-2027)
Figure 14. Global Adoptive Cell Therapy Market Share by Players in 2020
Figure 15. Global Top Adoptive Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adoptive Cell Therapy as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Adoptive Cell Therapy Revenue in 2020
Figure 17. Global Adoptive Cell Therapy Revenue Market Share by Type (2016-2021)
Figure 18. Global Adoptive Cell Therapy Revenue Market Share by Type (2022-2027)
Figure 19. North America Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Adoptive Cell Therapy Market Share by Type (2016-2027)
Figure 21. North America Adoptive Cell Therapy Market Share by Application (2016-2027)
Figure 22. North America Adoptive Cell Therapy Market Share by Country (2016-2027)
Figure 23. United States Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Adoptive Cell Therapy Market Share by Type (2016-2027)
Figure 27. Europe Adoptive Cell Therapy Market Share by Application (2016-2027)
Figure 28. Europe Adoptive Cell Therapy Market Share by Country (2016-2027)
Figure 29. Germany Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Adoptive Cell Therapy Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Adoptive Cell Therapy Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Adoptive Cell Therapy Market Share by Region (2016-2027)
Figure 39. China Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Adoptive Cell Therapy Market Share by Type (2016-2027)
Figure 47. Latin America Adoptive Cell Therapy Market Share by Application (2016-2027)
Figure 48. Latin America Adoptive Cell Therapy Market Share by Country (2016-2027)
Figure 49. Mexico Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Adoptive Cell Therapy Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Adoptive Cell Therapy Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Adoptive Cell Therapy Market Share by Country (2016-2027)
Figure 55. Turkey Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Novartis Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
Figure 59. Juno Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
Figure 60. Kite Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
Figure 61. Adaptimmune Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
Figure 62. Fibrocell Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
Figure 63. Lineage Cell Therapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
Figure 64. BioTime Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
Figure 65. Vericel Corporation Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
Figure 66. Regeneus Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
Figure 67. Anhui Anke Biotechnology Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
Figure 68. Cellectis Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
Figure 69. NantKwest Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
Figure 70. SorrentoTherapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
Figure 71. Bellicum Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界の養子細胞移植療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Adoptive Cell Transfer Therapy Market The global Adoptive Cell Transfer Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data int…- 世界の変形性関節症幹細胞治療市場規模・現状・予測（2021年-2027年） Osteoarthritis is one of the chronic conditions for joints which results in the breakdown and eventual loss of the cartilage of one or more joints. This can affect joints including hips, lower back, neck, small joints of the fingers, and the base of the thumb and big toe. The expected growth is beca…
- 世界の多発性骨髄腫用CART細胞療法市場規模・現状・予測（2021年-2027年） CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it i…
- 世界の多発性骨髄腫用CART細胞療法市場規模・現状・予測（2021年-2027年） CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it i…
- 世界のがん幹細胞（CSC）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cancer Stem Cell Therapy Market The global Cancer Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …